Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

Marketing 173

Marketing Sales Manufacturing Drugs 173

Drug Channels

OCTOBER 18, 2022

Some major biological reference products have now lost a majority of their unit sales to their biosimilars. Below, we share our estimates for wholesalers’ gross margins for brand-name, generic, and biosimilar drugs. We then explain the channel dynamics behind biosimilar and generic drugs’ profits.

Drugs 97

Drugs Generic Drugs Branding Sales 97

Camargo

NOVEMBER 11, 2020

Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product. Labeling regulations prohibit reminder ads for products with boxed warnings, which the FDA requires when a drug product has very serious risks.

Development 242

Development Bioequivalency Generic Drugs Production 242

Pharmaceutical Technology

MAY 16, 2023

increase in market capitalisation over Q1 2023, fuelled by its robust portfolio of diabetes and obesity treatments – in particular, its line of glucagon-like peptide 1 receptor agonist (GLP-1) Type 2 diabetes drugs Ozempic, Rybelsus and Victoza. Novo Nordisk reported an 18.2% million by 2029.

Marketing 130

Marketing Sales Generic Drugs Vaccination 130

Pharmacy Checkers

FEBRUARY 5, 2021

For those of you looking for a methodologically strong analysis of international drug prices and a history of related studies, this is the report for you. In looking at all drugs, brand and generic, the percentage goes down to 256%. That’s because, as the report shows, generic drugs in the U.S.

Branding 97

Branding Drugs Sales Generic Drugs 97

Pharmacy Checkers

DECEMBER 5, 2019

A new Chinese law (in effect as of December 1, 2019) makes third-party online platform medicine sales legal, appropriately ends a draconian definition of counterfeit drugs, and effectively decriminalizes personal drug importation, but with a lot of gray! Buying Drugs Online from Retail Platforms is Legal.

Sales 64

Sales Medicine Pharmacy Drugs 64

Pharmaceutical Technology

SEPTEMBER 15, 2022

Various factors have contributed to the need and growth of API chemical suppliers such as rising healthcare expenditure, increasing disposable incomes, growing geriatric population, increasing incidence of chronic diseases, patent expiration of blockbuster drugs, increased consumption of generic drugs, and intervention of the new generation APIs.

Marketing 100

Marketing Manufacturing Generic Drugs Containment 100

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

Marketing 130

Marketing Sales Manufacturing Drugs 130

Pharmaceutical Technology

SEPTEMBER 7, 2022

The list includes companies offering various products and services, including but not limited to: · Over-the-counter drugs. Prescription refill and generic drug programmes. Speciality care. Compounding services. Pharmacogenetics testing. Filling services. Proprietary pharmaceutical, nutraceutical, and cosmeceutical products.

Pharmacy 113

Pharmacy Containment Generic Drugs Production 113

pharmaphorum

SEPTEMBER 9, 2022

Novo Nordisk can be credited with re-invigorating the market for obesity drug therapies with its GLP-1 agonist therapies – Saxenda (liraglutide) and Wegovy (semaglutide) – which collectively saw sales increase 84% to $950 million, despite some supply constraints for Wegovy. billion in 2025.

Generic Drugs 113

Generic Drugs Sales Marketing Drugs 113

pharmaphorum

AUGUST 20, 2020

Shares in Teva were down sharply this week after the US Department of Justice filed a complaint that the company paid illegal kickbacks to patient groups to boost sales of its multiple sclerosis drug Copaxone (glatiramer). The allegation is that Teva’s subsidiaries Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc.

Generic Drugs 115

Generic Drugs Sales Pharmacy Pharma Companies 115

pharmaphorum

MARCH 5, 2021

Copaxone (glatiramer) was once a mainstay of Teva’s portfolio with blockbuster sales that the Israel-based pharma fought hard to protect, including releasing a long-acting version to counter cheaper copycat drugs. In the end it wasn’t enough and sales last year were $213 million, a fraction of the $4.3

Drugs 98

Drugs Sales Pharma Companies Generic Drugs 98

Pharma in Brief

FEBRUARY 8, 2024

The Notice advises that if an innovative drug is categorized as “Dormant” in Health Canada’s Drug Product Database, then a generic manufacturer can compare its drug against an alternate CRP, which could include another generic drug, when filing an Abbreviated New Drug Submission ( ANDS ).

Production 52

Production Generic Drugs Drugs Bioequivalency 52

pharmaphorum

OCTOBER 28, 2021

Merck has already filed for approval of molnupiravir in the US, Europe and Canada and said today that it expects to make around $1 billion in sales this year if approved, rising to $5 billion in 2022. The post Generic pill could be alternative to oral antivirals in COVID-19 appeared first on.

Generic Drugs 98

Generic Drugs Sales Drugs Licensing 98

XTalks

JANUARY 20, 2025

While the deal required regulatory divestitures, including the sale of Otezla (apremilast) to Amgen for $13.4 Blockbuster products like Botox (botulinum toxin) and Restasis (cyclosporine) provided Actavis with high-margin, branded revenue streams that complemented its existing generic drug business.

Marketing 104

Marketing Botox Life Science Pharma Companies 104

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. The top 40 best-selling oncology drugs in 2023, informed by 2022 sales statistics, mark significant milestones in cancer treatment and research.

FDA Approval 101

FDA Approval Drugs Sales Development 101

Camargo

DECEMBER 9, 2020

House of Representatives passed the “ Fairness in Orphan Drug Exclusivity Act ” to require proof from biopharma companies introducing improved versions of orphan drugs that they do not expect to recoup R&D costs through US sales in 12 years. GDUFA has changed this picture, at least for complex drug products.

Development 140

Development Production Drugs FDA Approval 140

pharmaphorum

JULY 29, 2021

Now, interchangeable status means that is considered to have no clinically meaningful difference to Lantus in safety, purity or potency, so can be substituted for the reference drug without any prescriber intervention – just like a regular generic drug can in many US states.

Insulin 98

Insulin Drugs Production Generic Drugs 98

pharmaphorum

NOVEMBER 2, 2020

Mylan’s $12 billion takeover of Pfizer’s Upjohn unit has been cleared by the US authorities, but on the condition that the two companies divest various generic drug products. Once formed, Viatris will be a generics behemoth with annual sales of around $19 to $20 billion and operations in 165 markets around the word.

Generic Drugs 52

Generic Drugs Contract Manufacturing Production Manufacturing 52

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. The company is comprised of several units, and the largest is Johnson & Johnson’s pharma unit which generated $52.56 billion in pharmaceutical sales from 2021. billion the drug generated in 2021. billion, a 42.74

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

FEBRUARY 2, 2022

If approved, the new drug would be sold through the sales channels set up by Pharming for Ruconest (conestat alfa), its treatment for rare disease hereditary angioedema (HAE) which is facing increasing competition in the marketplace from drugs like Takeda’s Takhzyro (lanadelumab).

Trials 52

Trials Drugs Sales Generic Drugs 52

pharmaphorum

JULY 29, 2021

The drugmaker specialises in selling generic drugs that are hard to manufacture, which places a barrier to widespread generic competition. ” Advanz itself was directly fined £40.9 million, while private equity firms HgCapital and Cinven – which previously owned the business – were fined £8.6 million and £51.9

Drugs 98

Drugs Marketing Generic Drugs Hormones 98

pharmaphorum

NOVEMBER 26, 2020

For Pawlu, COVID-19 has highlighted how we transform the way the industry works – from manufacturing and supply chains, to sales and detailing – in a way that ensures everyone can access the high quality, affordable medicines they need to live happier, healthier lives. About the interviewee.

Production 111

Production Manufacturing Sales Marketing 111

pharmaphorum

MARCH 16, 2022

Viatris’ generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been cleared for the same indications as the brand, namely maintenance treatment for asthma and chronic obstructive pulmonary disease (COPD).

FDA Approval 59

FDA Approval Generic Drugs Marketing Drug Delivery 59

pharmaphorum

JANUARY 25, 2022

.” The online pharmacy launch comes a few weeks after Cuban set up a pharmacy benefit manager (PBM) operation – the Mark Cuban Cost Plus Drug Company (MCCPDC) – promising to cut out the middleman in the medicines supply chain so it can eliminate markups on generic drugs and pass savings on to its customers.

Medicine 52

Medicine Pharmacy Generic Drugs Drugs 52

FDA Law Blog

MARCH 5, 2024

According to AstraZeneca, the statute defines a qualifying single source drug by reference to its individual “approval,” and “any other reading. by compelling sales of its products at well-below market prices.” contradicts the plain text of the statute and therefore must be set aside.” see also 42 U.S.C. 1320f-1(e)(1)(A).

Generic Drugs 64

Generic Drugs Marketing Drugs Production 64

Pharma in Brief

AUGUST 9, 2021

Rolling submissions, which are currently in use for COVID-19 drugs, would be extended to other drugs, such as those which address significant new and emerging infectious diseases in Canada, or which treat, prevent, or diagnose serious or severely debilitating diseases or conditions. Biologic Drugs. Labelling.

Regulation 98

Regulation Drugs Manufacturing Production 98

pharmaphorum

JUNE 3, 2021

The US regulator approved Lybalvi (olanzapine/samidorphan) for both indications sought – schizophrenia and bipolar I disorder – with data on its label that includes a claim of less weight gain with olanzapine on its own, a big problem with the widely-used generic drug that affects compliance with treatment.

FDA Approval 52

FDA Approval Marketing Branding Generic Drugs 52

The Pharma Data

DECEMBER 28, 2020

This further highlights Amphastar’s considerable abilities to bring complex generic drugs to the market, and more specifically, our strong peptide capabilities.” sales for Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar, 1 mg, were approximately $144 million, and the overall U.S. ” According to IQVIA, the U.S.

Bioequivalency 52

Bioequivalency Production Sales Marketing 52

XTalks

FEBRUARY 5, 2024

In the dynamic landscape of oncology therapeutics, understanding the trends and performances of leading drugs is crucial for stakeholders across the healthcare and life sciences sectors. The top 40 best-selling oncology drugs in 2023, informed by 2022 sales statistics, mark significant milestones in cancer treatment and research.

FDA Approval 52

FDA Approval Drugs Sales Development 52

Druggist

SEPTEMBER 30, 2020

Buscopan vs Mebeverine over the counter availability and age restrictions The table below summarises over the counter availability of both drugs and age restrictions associated with each brand. General sale medicines (GSL) can be sold in any retail outlets, commonly sold in supermarkets (e.g. Buy on Amazon Price incl.

Pharmacy 98

Pharmacy Containment Drugs Branding 98

FDA Law Blog

JUNE 16, 2023

Kirschenbaum — On May 24, Minnesota enacted the Commerce and Consumer Protection Omnibus Bill, Senate File 2744 ( SF 2744 ), which significantly expands the state’s existing drug pricing activities with serious implications for all drug manufacturers, and particularly generic drug manufacturers.

Drugs 45

Drugs Manufacturing Generic Drugs Production 45

XTalks

FEBRUARY 8, 2021

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “generic” drugs of the biopharma world.

Production 78

Production Insulin Branding Generic Drugs 78

Pharmaceutical Technology

JULY 10, 2008

As the blockbuster drugs of the 90s that earned the industry billions reach their patent shelf lives, pharmaceutical companies require new medicines to sustain an estimated $157bn worth of sales.

Medicine 100

Medicine Clinical Trials Clinical Trials Development 100

The Pharma Data

MARCH 9, 2021

“This first-to-market generic version of AZOPT ® (brinzolamide ophthalmic suspension) 1% in the U.S. provides patients with another important treatment option,” said Christine Baeder, SVP, Chief Operating Officer US Generics, Teva USA. Currently, one in ten generic prescriptions dispensed in the U.S.

Doctors 52

Doctors Doctor Production Generic Drugs 52

Pharma in Brief

JUNE 21, 2020

They include: (1) new factors for assessing excessive pricing, (2) new powers to collect information regarding these factors, (3) new obligations to report indirect price adjustments, (4) risk-based reporting obligations for OTC and generic drugs, and (5) a revised list of international price comparator countries (the PMPRB11 ).

Medicine 40

Medicine Regulation Sales Generic Drugs 40

FDA Law Blog

AUGUST 29, 2024

After all, as we have written before in other contexts ( i.e. , the BLOCKING Act), “[I]f you limit a generic drug manufacturer’s ability to settle cases, that manufacturer does not settle fewer cases, it submits fewer Paragraph IV ANDAs. And fewer ANDAs means less, not more, generic drug competition.”

Production 59

Production Licensing Licensing Generic Drugs 59